Skip to main content
AAN.com

Abstract

Cognition is 1 of 4 domains measured by the NIH Toolbox for the Assessment of Neurological and Behavioral Function (NIH-TB), and complements modules testing motor function, sensation, and emotion. On the basis of expert panels, the cognition subdomains identified as most important for health, success in school and work, and independence in daily functioning were Executive Function, Episodic Memory, Language, Processing Speed, Working Memory, and Attention. Seven measures were designed to tap constructs within these subdomains. The instruments were validated in English, in a sample of 476 participants ranging in age from 3 to 85 years, with representation from both sexes, 3 racial/ethnic categories, and 3 levels of education. This report describes the development of the Cognition Battery and presents results on test-retest reliability, age effects on performance, and convergent and discriminant construct validity. The NIH-TB Cognition Battery is intended to serve as a brief, convenient set of measures to supplement other outcome measures in epidemiologic and longitudinal research and clinical trials. With a computerized format and national standardization, this battery will provide a “common currency” among researchers for comparisons across a wide range of studies and populations.

Get full access to this article

View all available purchase options and get full access to this article.

DISCLAIMER

The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of NIH or any of the sponsoring organizations, agencies, or the U.S. government.

REFERENCES

1.
Diamond A. Normal development of prefrontal cortex from birth to young adulthood: cognitive functions anatomy and biochemistry. In:, Stuss D, Knight B, editors. Principles of Frontal Lobe Function. New York: Oxford University Press; 2002:466–503.
2.
Diamond A. Frontal lobe involvement in cognitive changes during the first year of life. In:, Gibson KR, Petersen AC; Council SSR, editors. Brain Maturation and Cognitive Development: Comparative and Cross-cultural Perspectives. New York: De Gruyter; 1991:127–180.
3.
Zelazo PD, Carlson SM, Kesek A. Development of executive function in children. In:, Nelson CA, Luciana M, editors. Handbook of Developmental Cognitive Neuroscience, 2nd ed. Cambridge, MA: MIT Press; 2008:553–574.
4.
Daniels K, Toth J, Jacoby L. The aging of executive functions. In:, Bialystok E, Craik FIM, editors. Lifespan Cognition: Mechanisms of Change. New York: Oxford University Press; 2006:96–111.
5.
Zelazo PD, Craik FI, Booth L. Executive function across the life span. Acta Psychol 2004;115:167–183.
6.
Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD. The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cogn Psychol 2000;41:49–100.
7.
Wiebe SA, Sheffield T, Nelson JM, Clark CAC, Chevalier N, Espy K. The structure of executive function in 3-year-olds. J Exp Child Psychol 2011;108:436–452.
8.
Durston S, Davidson MC, Tottenham N, et al. A shift from diffuse to focal cortical activity with development. Dev Sci 2006;9:1–8.
9.
Zelazo PD. The Dimensional Change Card Sort (DCCS): a method of assessing executive function in children. Nature Protocols 2006;1:297–301.
10.
Weintraub S. Neuropsychological assessment of mental state. In:, Mesulam MM, editor. Principles of Cognitive and Behavioral Neurology. New York: Oxford University Press; 2000:121–173.
11.
Swensen A, Birnbaum HG, Ben Hamadi R, Greenberg P, Cremieux PY, Secnik K. Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. J Adolesc Health 2004;35:346.e341–346.e349.
12.
Mesulam M. A cortical network for directed attention and unilateral neglect. Ann Neurol 1981;10:309–325.
13.
Posner MI, Petersen SE. The attention system of the human brain. Annu Rev Neurosci 1990;13:25–42.
14.
D'Esposito M, Aguirre GK, Zarahn E, Ballard D, Shin RK, Lease J. Functional MRI studies of spatial and nonspatial working memory. Cogn Brain Res 1998;7:1–13.
15.
Conlin JA, Gathercole SE, Adams JW. Children's working memory: investigating performance limitations in complex span tasks. J Exp Child Psychol 2005;90:303–317.
16.
Salthouse TA, Meinz EJ. Aging, inhibition, working memory, and speed. J Gerontol B Psychol Sci Soc Sci 1995;50:P297–P306.
17.
Hitch GJ, Towse JN, Hutton U. What limits children's working memory span? Theoretical accounts and applications for scholastic development. J Exp Psychol Gen 2001;130:184–198.
18.
de Jong PF, Olson RK. Early predictors of letter knowledge. J Exp Child Psychol 2004;88:254–273.
19.
de Jong PF. Working memory deficits of reading disabled children. J Exp Child Psychol 1998;70:75–96.
20.
Riggs KJ, McTaggart J, Simpson A, Freeman RP. Changes in the capacity of visual working memory in 5- to 10-year-olds. J Exp Child Psychol 2006;95:18–26.
21.
Salthouse TA, Coon VE. Interpretation of differential deficits: the case of aging and mental arithmetic. J Exp Psychol Learn Mem Cogn 1994;20:1172–1182.
22.
Corkin S, Amaral DG, Gonzalez RG, Johnson KA, Hyman BT. H. M.'s medial temporal lobe lesion: findings from magnetic resonance imaging. J Neurosci 1997;17:3964–3979.
23.
Bauer PJ. Remembering the Times of Our Lives: Memory in Infancy and Beyond. Mahwah, NJ: Lawrence Erlbaum Associates; 2007.
24.
Perner J, Ruffman T. Episodic memory and autonoetic consciousness: developmental evidence and a theory of childhood amnesia. J Exp Child Psychol 1995;59:516–548.
25.
Gadian DG, Aicardi J, Watkins KE, Porter DA, Mishkin M, Vargha-Khadem F. Developmental amnesia associated with early hypoxic-ischaemic injury. Brain 2000;123(pt 3):499–507.
26.
Albert MS. Cognitive and neurobiologic markers of early Alzheimer disease. Proc Natl Acad Sci USA 1996;93:13547–13551.
27.
Mitchell AS, Dalrymple-Alford JC. Lateral and anterior thalamic lesions impair independent memory systems. Learn Mem 2006;13:388–396.
28.
Price CJ. The anatomy of language: contributions from functional neuroimaging. J Anat 2000;197(pt 3):335–359.
29.
Schmidt FL, Hunter J. General mental ability in the world of work: occupational attainment and job performance. J Pers Soc Psychol 2004;86:162–173.
30.
Grober E, Sliwinski M. Development and validation of a model for estimating premorbid verbal intelligence in the elderly. J Clin Exp Neuropsychol 1991;13:933–949.
31.
Manly JJ, Byrd DA, Touradji P, Stern Y. Acculturation, reading level, and neuropsychological test performance among African American elders. Appl Neuropsychol 2004;11:37–46.
32.
Manly JJ, Jacobs DM, Sano M, et al. Effect of literacy on neuropsychological test performance in nondemented, education-matched elders. J Int Neuropsychol Soc 1999;5:191–202.
33.
Cattell RB. Intelligence: Its Structure, Growth and Action. Amsterdam: Elsevier; 1987.
34.
Kastner JW, May W, Hildman L. Relationship between language skills and academic achievement in first grade. Percept Mot Skills 2001;92:381–390.
35.
Fenson L, Dale PS, Reznick JS, Bates E, Thal DJ, Pethick SJ. Variability in early communicative development. Monogr Soc Res Child Dev 1994;59:1–173.
36.
Gleason JB, Ratner NB, editors. The Development of Language, 7th ed. Boston: Pearson/Allyn & Bacon; 2009.
37.
Hirsh-Pasek K, Golinkoff RM. The Origins of Grammar: Evidence from Early Language Comprehension. Cambridge, MA: M.I.T. Press; 1996.
38.
Kalmar JH. Information processing speed in multiple sclerosis: a primary deficit? In:, DeLuca J, Kalmar JH, editors. Information Processing Speed in Clinical Populations. New York: Taylor & Francis; 2007:153–172.
39.
Fry AF, Hale S. Relationships among processing speed, working memory and fluid intelligence in children. Biol Psychol 2000;54:1–34.
40.
Salthouse TA. Aging and measures of processing speed. Biol Psychol 2000;54:35–54.
41.
Hawkins KA. Indicators of brain dysfunction derived from graphic representations of the WAIS-III/WMS-III technical manual clinical samples data: a preliminary approach to clinical utility. Clin Neuropsychologist 1998;12:535–551.
42.
DeLuca J, Kalmar JH. Information Processing Speed in Clinical Populations. London: Psychology Press; 2007.
43.
Zelazo PD, Bauer PJ, Editors. National Institutes of Health Toolbox—Cognitive Function Battery (NIH Toolbox CFB): Validation for Children Between 3 and 15 Years. Monogr Soc Res Child Dev (in press).
44.
Rueda MR, Fan J, McCandliss BD, et al. Development of attentional networks in childhood. Neuropsychologia 2004;42:1029–1040.
45.
Mungas D, Reed BR, Tomaszewski Farias S, DeCarli C. Criterion-referenced validity of a neuropsychological test battery: equivalent performance in elderly Hispanics and non-Hispanic Whites. J Int Neuropsychol Soc 2005;11:620–630.
46.
Crane PK, Narasimhalu K, Gibbons LE, et al. Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. J Clin Epidemiol 2008;61:1018–1027.e9.
47.
Mungas D, Widaman KF, Reed BR, Tomaszewski Farias S. Measurement invariance of neuropsychological tests in diverse older persons. Neuropsychology 2011;25:260–269.
48.
Bauer PJ. Long-term recall memory: behavioral and neuro-developmental changes in the first two years of life. Curr Dir Psychol Sci 2002;11:137–141.
49.
Bauer PJ. Developments in declarative memory. Psychol Sci 2005;16:41–47.
50.
Bauer PJ. Constructing a past in infancy: a neuro-developmental account. Trends Cogn Sci 2006;10:175–181.
51.
Salthouse TA, Babcock RL, Shaw RJ. Effects of adult age on structural and operational capacities in working memory. Psychol Aging 1991;6:118–127.
52.
Wechsler D. WPPSI-III Wechsler Preschool Primary Scale of Intelligence, 3rd ed. San Antonio: Psychological Corporation; 2002.
53.
Dunn LM, Dunn LM. Peabody Picture Vocabulary Test Fourth Edition (PPVT-IV). Bloomington, MN: NCS Pearson; 2007.
54.
Zelazo PD, Anderson JE, Richler J, Wallner-Allen K, Beaumont JL, Weintraub S. NIH Toolbox cognitive function battery (CFB): measuring executive function and attention. Monogr Soc Res Child Dev (in press).
55.
Johnson MH. Interactive specialization: a domain-general framework for human functional brain development? Developmental Cognitive Neuroscience 2011;1:7–21.

Information & Authors

Information

Published In

Neurology®
Volume 80Number 11_supplement_3March 12, 2013
Pages: S54-S64
PubMed: 23479546

Publication History

Received: June 6, 2012
Accepted: November 15, 2012
Published online: March 11, 2013
Published in print: March 12, 2013

Permissions

Request permissions for this article.

Disclosure

S. Weintraub is funded by NIH grants R01DC008552, P30AG013854, and the Ken and Ruth Davee Foundation, and conducts clinical neuropsychological evaluations (35% effort) for which her academic-based practice clinic bills. S. Dikmen receives research grant funding from NIH R01 NS058302 and R01HD061400, NIDRR H133A080035, NIDRR H133G090022, and NIDRR, H133A980023, and DoD W81XWH-0802-0159. R. Heaton is funded by NIH grants P30MH062512, P50DA026306, P01DA012065, R01MH060720, R01MH073433, R01MH058076, R01MH078748, R01MH078737, U01MH083506, R01MH083552, and R01MH081861. D. Tulsky is funded by NIH contracts H133B090024, H133N060022, H133G070138, B6237R, cooperative agreement U01AR057929, and grant R01HD054659. He has received consultant fees from the Institute for Rehabilitation and Research, Frazier Rehabilitation Institute/Jewish Hospital, Craig Hospital, and Casa Colina Centers for Rehabilitation. P. Zelazo serves on the editorial boards of Child Development, Development and Psychopathology, Frontiers in Human Neuroscience, Cognitive Development, Emotion, and Developmental Cognitive Neuroscience, and Monographs of the Society for Research in Child Development. He is a Senior Fellow of the Mind and Life Institute and President of the Jean Piaget Society. He receives research funding from the Canadian Institute for Health Research (grant 201963), NIDDK/NICHD (1699-662-6312), and the Baumann Foundation. P. Bauer is funded by NIH grant HD067359. N. Carlozzi is funded by NIH grant R03NS065194 and by contracts H133B090024, B6237R, and H133G070138; she previously received funding from NIH grant H133A070037-08A and a grant from the NJ Department of Health and Senior Services. J. Slotkin, D. Blitz, and K. Wallner-Allen report no disclosures. N. Fox is funded by NIH grants R37HD017899, MH074454, U01MH080759, R01MH091363, P50MH078105, and P01HD064653. He serves on the scientific board of the National Scientific Council for the Developing Child. J. Beaumont served as a consultant for NorthShore University HealthSystem, FACIT.org, and Georgia Gastroenterology Group PC. She received funding for travel as an invited speaker at the North American Neuroendocrine Tumor Symposium. D. Mungas is funded by research grants from the National Institute on Aging and a grant from the California Department of Public Health California Alzheimer's Disease Centers program. C. Nowinski receives or has received research support from the NIH (contracts HHSN265200423601C, HHSN260200600007C, and HHSN267200700027C), the Department of Veteran's Affairs, the Analysis Group, Novartis, and Teva Pharmaceuticals. She has also received honoraria for writing and updating an article for Medlink. J. Richler is funded by NIH/NCRR grant UL1RR025761. J. Deocampo and J. Anderson report no disclosures. J. Manly is funded by NIH grants R01AG028786 and R01AG037212; she previously received funding from NIH grant R01AG016206 and a grant from the Alzheimer's Association (IIRG 05-14236). B. Borosh, R. Havlik, and K. Conway report no disclosures. E. Edwards is the Director of the Division of Extramural Research at NCCAM. Dr. Edwards declares that except for income received from her primary employer, no financial support or compensation has been received from any individual or corporate entity over the past 3 years for research or professional service and there are no personal financial holdings that could be perceived as constituting a potential conflict of interest. L. Freund reports no disclosures. J. King is the NIA Project Scientist for the NIH cooperative agreements U01AG014289, U01AG014276, U01AG14260, U01AG14282, and U01AG014263 (comprising the ACTIVE clinical trial). C. Moy and E. Witt report no disclosures. R. Gershon has received personal compensation for activities as a speaker and consultant with Sylvan Learning, Rockman, and the American Board of Podiatric Surgery. He has several grants awarded by NIH: N01-AG-6-0007, 1U5AR057943-01, HHSN260200600007, 1U01DK082342-01, AG-260-06-01, HD05469; NINDS: U01 NS 056 975 02; NHLBI K23: K23HL085766 NIA; 1RC2AG036498-01; NIDRR: H133B090024; OppNet: N01-AG-6-0007. Go to Neurology.org for full disclosures.

Study Funding

This study is funded in whole or in part with Federal funds from the Blueprint for Neuroscience Research, NIH, under contract no. HHS-N-260-2006-00007-C.

Authors

Affiliations & Disclosures

Sandra Weintraub, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
Non profit: Dominantly Inherited Alzheimer's Network-neuropsychological assessment
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
2005- Editorial Board, Alzheimer's and Dementia: Journalof the Alzheimer's Association2005- International Advisory Board, Turkish Journal ofNeurology2006- Editorial Board, Dementia & Neuropsychologia,Journal of the Brazilian Academy of Neurology
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
D. Research Support (Past 3 Years)Ongoing Research SupportNS1P30 AG13854-06 (Mesulam, PI) 7/1/96 - 6/30/16 2.28 calendarNIH/NIAAlzheimer's Disease Core CenterThe major goal of this project is to operate anAlzheimer's Disease Core Center (ADCC) at NorthwesternUniversity. 1 T32 AG20506-01-05 (Disterhoft, PI)5/01/07-4/30/17NIH/NIA Mechanisms of Aging and Dementia Training ProgramA broadly based multidisciplinary postdoctoral andpredoctoral training program focusing on the mechanisms ofaging and dementia, in particular Alzheimer's Disease. Molecular, cellular, systems, behavioral,neuropsychological and clinical neuroscience approachesare represented. Support for four postdoctoral and fourpredoctoral positions. No salary support.AG-260-06-01 (Gershon, PI)10/01/2006-09/30/2011 1.20 calendar NIHNIH Toolbox for Assessment of Neurological and BehavioralFunctionThe NIH Toolbox initiative is a response to the need forbrief, comprehensive assessment tools that will beresponsive to clinicians and researchers in a variety ofsettings. The initiative will take advantage ofstate-of-the-art psychometric research and novel testingmethods to develop an innovative approach to neurologicaland behavioral health measurement, with a particularemphasis on measuring outcomes in longitudinalepidemiologic studies and prevention of interventiontrials across the lifespan.R01 (Mesulam, PI) 05/01/2007 - 11/30/20171.66 calendar NIDCDLanguage in Primary Progressive AphasiaThe major goal of this project is to investigate thelanguage disorder and treatment modalities in primaryprogressive aphasia (PPA).
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Sureyya S. Dikmen, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Research grant funding as an investigator from NIH R01 NS058302 and R01HD061400, NIDRR H133A080035, NIDRR H133G090022, and NIDRR, H133A980023, and DoD W81XWH-0802-0159
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Robert K. Heaton, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
1) NINCDS, advisor, 2007-2010
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
(1) Journal of the International NeuropsychologicalSociety, editorial board, 2000-present, (2) Journal ofClinical and Experimental Neuropsychology, editorialboard, 2000-present, (3) The Clinical Neuropsychologist,editorial board, 2000-present
Patents:
1.
NONE
Publishing Royalties:
1.
(1) Revised Comprehensive Norms for and ExpandedHalstead-Reitan Battery: Demographically AdjustedNeuropsychological Norms for African American andCaucasian Adults, Psychological Assessment Resources,Inc., 1991-present(2) Revised Comprehensive Norms for and ExpandedHalstead-Reitan Battery: Demographically AdjustedNeuropsychological Norms for African American andCaucasian Adults Scoring Program, Psychological AssessmentResources, Inc., 1994-present(3) Wisconsin Card Sorting Test Manual-Revised andExpanded, Psychological Assessment Resources, Inc.,1991-present
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
(1)NIH P30 MH62512, Co-Investigator, 2006-2010, (2)NIH P50DA26306, Co-Investigator, 2009-2010, (3) NIH P01 DA12065,Co-Investigator, 2005-2010, (4) NIH R01 MH60720,Co-Investigator, 2006-2010, (5) NIH R01 MH73433, PrincipalInvestigator, 2005-2010, (6) NIH N01 MH22005,Co-Investigator, 2002-2010, (7) NIH R01 MH58076,Co-Investigator, 2006-2010, (8) NIH R01MH78748,Co-Investigator, 2007-2010, (9) NIH R01 MH78737,Co-Investigator, 2007-2010, (10) NIH U01 MH83506,Co-Investigator, 2008-2010, (11) NIH R01MH83552,Co-Investigator, 2008-2010, (12) NIH R01 MH81861,Co-Investigator, 2008-2010, (13) NIH P30MH062512-11,Principal Investigator, 2011-2016.
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
David S. Tulsky, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
Served on the NIH Toolbox SCientific advisory board (nocompensation but institution had subcontract with NIH/leadinstitution for Toolbox and I had some salary support).
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Received reimbursement for expenses for travel to NIHSteering committee meetings, meetings directly related tothis research, and dissemination of this research atnational conferences.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Institution had subcontract to work on this project. Thiscontract provided 5-10% salary support over the last 5years to compensate directly for the work I was doing onthe project
Research Support, Government Entities:
1.
NIH Toolbox Contract - with Northshore - NIH. (NIA). 5years support at 5 - 10% full time equivalent.
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Philip D. Zelazo, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
Senior Fellow of the Mind and Life InstitutePresident, Jean Piaget Society
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
8 June, 2012, Invited address, Symposium on Research in Child Language Disorders, Madison, WI, honorarium and travel expenses10 Jan 12, Invited address, The 1st Annual Michael Chandler Lecture, University of British Columbia, BC, honorarium and travel expenses2 -3 Dec 11, Invited speaker, National Conference of State Legislatures (NCSL), Early Learning Fellows Meeting, Tampa, Florida, honorarium and travel expenses16 Nov 11, Invited speaker, Washington State-Frontiers of Innovation Working Meeting, Seattle, WA, honorarium and travel expenses10-11 Nov 11, Invited speaker, Society for Neuroscience Satellite Workshop, "Social Neuroscience of Human-Animal Interaction," Washington, DC, honorarium and travel expenses27-28 Oct 11, Invited speaker, Inter-American Development Bank (IDB), Workshop on youth development, Washington, DC, honorarium and travel expenses22-23 Sept 11, Invited speaker, 3rd Biennial Urie Bronfenbrenner Conference: The Neuroscience of Risky Decision-making, Cornell University, Ithaca, NY, honorarium and travel expenses19 Aug 11, Invited speaker, University of Florida, Gainesville, honorarium and travel expenses18-21 May 11, Invited speaker, 22nd Annual International Trauma Conference: Psychological Trauma: Neuroscience, Attachment, and Therapeutic Interventions, Boston, honorarium and travel expenses6-8 April 11, Invited speaker, Adolescence: Exploration and Self-Regulation of the Unknown (Jacobs Foundation Workshop), Marburg Castle, Lake Constance, Germany, honorarium and travel expenses
Editorial Boards:
1.
Child Development, Editorial BoardDevelopment and Psychopathology, Editorial BoardFrontiers in Human Neuroscience, Editorial BoardCognitive Development, Editorial BoardEmotion, Editorial BoardDevelopmental Cognitive Neuroscience, Editorial BoardMonographs of the Society for Research in Child Development, Ediorial Advisor
Patents:
1.
NONE
Publishing Royalties:
1.
Oxford Handbook of Developmental Psychology, Oxford University Press, 2013
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
University of FloridaLehman College, City Univ of New York
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Canadian Institute for Health Research (Grant # 201963) NIDDK/NICHD (1699-662-6312)
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Patricia J. Bauer, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Monographs of the Society for Research in Child Development, Incoming Editor, 2011-2016
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
National Institutes of Health, 2012-2017: "Developments in extension of knowledge through integration of separate episodes" (R01 HD067359) National Institutes of Health, 2012-2014: Diversity supplement to "Developments in extension of knowledge through integration of separate episodes" (R01 HD067359)
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Noelle E. Carlozzi, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Received consulting fees from The Analysis Group(2011-present)
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
National Institute of Health; NIH Toolbox for Assessmentof Neurological and Behavioral Function; N01AG60007;co-investigator; 09/30/07-presentNational Institute on Disability and RehabilitationResearch; RRTC on Improving Measurement of MedicalRehabilitation Outcomes; H133B090024; co-investigator;10/01/09 - presentNational Institute on Disability and RehabilitationResearch; Quality of Life in Traumatic Brain InjuryResearch and Practice: Development of the TBI-QOL;H133G070138; co-investigator; 10/1/07 - 9/30/11
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Jerry Slotkin, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
David Blitz, MA
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Kathleen Wallner-Allen, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
I am currently employed by Westat as a Senior Study Director.
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Nathan A. Fox, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
National Scientific Council for the Developing Child (nonprofit entity)
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Penn State University speaker honorarium
Editorial Boards:
1.
International Journal of Behavioral Development AssociateEditor, 2009-2012
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NIH Toolbox, Executive Committee
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIMH MH093349, PI, 2011-2016
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Jennifer L. Beaumont, MS
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
North American Neuroendocrine Tumor Symposium, funding for travel as an invited speaker
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NorthShore University HealthSystems, FACIT.org, and Georgia Gastroenterology Group PC
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Dan Mungas, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
Steering Committee, NIH Neurobehavioral Toolbox Initiative
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Paid Consultant with NIH Neurobehavioral Toolbox Initiative
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
R01 AG10220 Mungas (PI) 8/15/08-05/31/13NIH/NIA"English and Spanish Assessment of Cognition in Elderly"The purpose of this grant is to develop and validatepsychometrically matched English and Spanish languageneuropsychological assessment instruments.Role: PIP30 AG10129 DeCarli (PI) 7/1/11-6/30/16NIH/NIA"UC Davis Alzheimer's Disease Center Core"Major goals of this project are to enroll, study andfollow a cohort of patients and control subjects who arethoroughly characterized, and longitudinally followed toautopsy. This provides a researchinfrastructure for clinical and basic studies of dementiain Northern California.Role: Co-Investigator, Clinical and Data Cores DHS 06-55311 Mungas (PI) 7/1/09-6/30/12California Department of Health Services "Alzheimer's Research Center of California"The major goals of this project are to provide dementiarelated clinical services, to education professional andnon-professional audiences, and to perform and promoteresearch on Alzheimer's disease and dementia.Role: PIP01 AG12435 Chui PI 9/1/08 - 8/31/13NIA/NIHThe Aging Brain: Ischemia, Vasculature, and ADThe major goal of this project is to determine howstructural changes in the cerebral vasculature affectbrain function and behavior in elderly persons.Role: Co-InvestigatorR01 AG019349 White PI 4/1/07 - 2/29/12NIA/NIHEpidemiology of Brain Aging in the Very OldThis is an epidemiological study of determinants ofdementia in very old Japanese American males living inHonolulu, Hawaii. Role: Co-InvestigatorR01 AG029672 Crane PI10/01/07 - 9/30/12NIA/NIHImproving Cognitive Outcome Precision & Responsivenesswith Modern PsychometricsThe major goal of this project is to use advancedpsychometric and statistical methods to improvesensitivity of neuropsychological tests to changes ofbrain structure associated with diseases of aging.Role: Co-InvestigatorN01-NS-6-2366 Kramer PI12/1/06-11/30/11NINDS/NIHFunding for Domain Specific Tasks of Executive Function.The overall goal of this 5 year project is to develop aneuropsychological test battery that reliably and validlyassesses domains of executive function for clinicalinvestigations and clinical trials that is adaptableacross a wide range of ages and disorders.Role: Site PI, UC Davis subcontractR13 AG030995 Mungas PI 4/1/08-3/31/13 NIA/NIHConference on Advanced Psychometric Methods in CognitiveAging ResearchThe purpose of this grant is to conduct a series of annualconferences on application of advanced psychometricmethods to cognitive aging research.Role: PIAG031563 Reed PI3/1/09 -2/28/14NIA/NIHBrain Pathologies, Reserve and Cognition in Aging andDementia.The goal of this project is to examine influences ofAlzheimer's disease, cerebrovascular disease, andcognitive reserve on cognitive function in older individuals.Role: Co-investigatorAG031252 Tomaszewski Farias PI 09/01/08-07/31/13 NIH/NIAUnderstanding the pathway to functional disability inAlzheimer's diseaseThe major goals of this project are to characterize thenatural course leading to disability and dementia, and toexamine how neuropsychological, neuropsychiatric, andmotor impairments influence this process. In addition, wewill examine how associated risk factors, such as generalhealth status and education, modify trajectories offunctional decline.AG021028 (Dr. DeCarli) 7/1/10 -6/30/15NIA/NIH $185,690Heterogeneity of Mild Cognitive Impairment (MCI)The goal of this project is to examine the clinical andneurobiological substrate of MCI in a large group of MCIpatients selected to have both memory and non-memoryimpairment.Role: Co-investigatorAG12975 Haan (PI) NIH/NIA 09/01/09-8/31/2013NIA/NIH 06/15/97-8/31/2013Epidemiology of Functional Status in Elderly HispanicsThe major goal of this grant is to prospectively follow2000 community-dwelling Latinos over age 60 living in theCentral Valley of California. Data were obtained on healthstatus, prevalence of functional impairments, risk factorsfor decline in physical and cognitive function and theprevalence and incidence of dementia in this group.Role: Co-investigator
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Cindy J. Nowinski, MD, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
I am a guest editor of the special Neurology issue of which this paper is going to be part of (if the paper is accepted).
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
1) Teva Neurosciences, Inc2) Novartis3) Analysis Group
Research Support, Government Entities:
1.
1) NIH, HHSN 2652004236-01C, co-I, 9/30/04-9/29/10;HHSN 260200600007C, co-I, 9/30/06-9/29/11;3U01AR052177-06S1, co-I, 09/28/04-4/29/11; HHSN 26720070027C, co-I, 6/01/11-9/30/12;1R01CA174452-01, co-I, 9/24/12-9/29/17 2) Department of Veteran Affairs, B6237R, co-I, 3/31/09-4/1/11.
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
National Quality Forum
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Jennifer Richler, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
Riley Child Development Center, Training on the Autism Diagnostic Observation Schedule (ADOS)Fort Wayne Community Schools, Training on the ADOS
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Indiana Clinical and Translational Sciences Institute, 2011-2013
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Joanne A. Deocampo, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
1) Minerals, associate editor, 2012-2012 (husband)
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
1) Georgia State University, postdoctoral research associate (current -self)2) Emory University, senior research associate (January 2008-July 2009 - self)3) Georgia State University, associate professor (2007-current - husband)
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
1) Southern Company, $5000. Carbon Sequestration Mineralogy and Geochemistry. (Husband)
Research Support, Government Entities:
1.
1) National Institutes of Health, N01 AG60007, senior research associate, 2008-2009 (self)2) National Institutes of Health, R01 DC012037, postdoctoral research associate, 2012 (self)3) National Science Foundation, "Acquisition of X-ray Diffraction Instrumentation for Mineralogical and Crystallographic Research and Education," 1029020, 10/1/11-9/30/13. P.I. (Husband)4) National Science Foundation (#EAR-1050246), Geobiology and Low-Temperature Geochemistry Program, "RAPID: Enhancing Biodegradation of Deepwater Horizon Contaminant Hydrocarbons in Louisiana Salt Marsh Using High Layer Charge Montmorillonites," : P.I. (Husband)5). United States Geological Survey, G11AC20071, "Reservoir Resources for Geological Carbon Sequestration in Georgia," 5/1/11-12/31/12, P.I. (Husband)6) State of Georgia Department of Transportation, 10-06, "A web-based petrologic and geochemical information system of aggregate sources for the Georgia Department of Transportation," 6/2010 - 6/2012, P.I. (Husband)
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
1) Petroleum Research Fund - American Chemical Society, PRF# 50759-UR2, "Experimental synthesis of authigenic lacustrine clay minerals: Hypothesis testing for modern and ancient depositional systems," 1/1/11 - 8/31/2014., Status: P.I. (Husband)
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Jacob E. Anderson, MA
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
University of Minnesota, Associate Scientist
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
One Tree Island Photography, Wedding PhotographerAugsburg College, BioPsychology Lab Technician
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Jennifer J. Manly, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Travel costs as a speaker at AAIC, Vancouver 2012,Alzheimer's Association (non-profit)E
Editorial Boards:
1.
Journal of the International Neuropsychological Society,associate editor, 2005 - present
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
1) National Institute on Aging, R01 AG028786, Role:Principal Investigator, 09/15/07 - 06/30/132) National Institute on Aging, R01 AG037212, Role:Co-Investigator, 05/01/10 - 04/30/15
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
2) Alzheimer's Association, IIRG-11-202789, Role:Principal Investigator, 08/15/11 - 08/14/14
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Beth Borosh, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Richard Havlik, MD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Westat, Inc. Rockville, MarylandAIDS Community Research Initiative of America (ACRIA) NY, NY
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Kevin Conway, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Emmeline Edwards, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Lisa Freund, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
Non-commercial entity: Department of Health and Human Resources (DHHS/National Institutes of Health (NIH/ National Institute of Child Health and Human Development (NICHD)Position: Program Officer
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Jonathan W. King, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
National Institute on Aging, NIH; program director
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Claudia Moy, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
currently a Federal government employee
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Ellen Witt, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Richard C. Gershon, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (S.W., B.B.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Rehabilitation Medicine (S.S.D.), University of Washington, Seattle, WA; Department of Psychiatry (R.K.H.), University of California, San Diego, CA; Department of Physical Medicine and Rehabilitation (D.S.T., N.E.C.), University of Michigan, Ann Arbor, MI; Institute of Child Development (P.D.Z., J.E.A.), University of Minnesota, Minneapolis, MN; Department of Psychology (P.J.B., J.A.D.) Emory University, Atlanta, GA; Department of Medical Social Sciences (J.S., D.B. J.L.B., C.J.N., R.C.G.), Northwestern University, Chicago, IL; Westat (K.W.-A., R.H.), Rockville, MD; Department of Human Development (N.A.F.), University of Maryland, College Park, MD; Department of Neurology (D.M.), University of California, Davis, CA; Department of Psychological and Brain Sciences (J.R.), Indiana University, Bloomington, IN; Cognitive Neuroscience Division (J.J.M.), Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Sergievsky Center, Columbia University, New York, NY; National Institute on Drug Abuse (K.C.), Rockville, MD; National Center for Complementary and Alternative Medicine (E.E.), Bethesda; National Institute of Child Health and Human Development (L.F.), Bethesda; National Institute on Aging (J.W.K.), Bethesda; National Institute of Neurological Disorders and Stroke (C.M.), Bethesda; and National Institute on Alcohol Abuse and Alcoholism (E.W.), Bethesda, MD.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
American Board of Podiatric SurgeryRockman et al.Sylvan Learning
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
National Institutes of Neurological Disorders and Stroke, HHSN 265200436, Co-Investigator, 2004-2009; National Institute of Arthritis and Musculoskeletal and Skin Diseases, U01 AR 052 177, Co-Investigator, 2004-2009;Heart, Lung and Blood Institute R01HL81485-03, Co-Investigator, 2005-2008;National Institutes of Health, U01 AR052177-01S1, Co-Investigator, 2005-2009;National Institutes of Health, CA 60068-11, Co-Investigator, 2005-2009;Centers for Medicare and Medicaid Services (CMS), "Post-Acute Care: Patient-Assessment Instrument Development", Site Principal Investigator, 2006-2008;National Institutes of Health, AG-260-06-01, Principal Investigator, 2006-2011;National Institutes of Neurological Disorders and Stroke, U01 NS 056 975 02, Co-Investigator, 2006-2011;National Institutes of Health,5U01AR052171-04, Site Principal Investigator, 2007-2008;NIDRR, H133B040032, Site Principal Investigator, 2007-2009;NIDRR, "Quality of Life in Traumatic Brain Injury Research and Practice: Development of the TBI-QO," Site Principal Investigator, 2007-2010;National Institutes of Health, HD05469, Site Principal Investigator, 2007-2012;National Institutes of Health, NHLBI K23 Award, Co-Investigator, 2007-2012;National Cancer Institute, CA 60068-13, Co-Investigator, 2007-2009;National Institutes of Health, "Interactive Mechanisms of Pelvic Pain," Site Principal Investigator, 2008-2013;National Institutes of Health. Modification No 005, HHSN260200600007, N01-AG-6-0007, Principal Investigator, 2008-2011;National Institutes of Health, Modification No 005, HHSN260200600007, N01-AG-6-0007, Principal Investigator, 2008-2011;National Institutes on Aging, 1RC2AG036498-01, Principal Investigator, 2009-2011;National Institutes of Health Roadmap Initiative, "PROMIS Technical Center", Principal Investigator, 2009-2013;NIDRR, "RRTC Measuring Rehabilitation Outcomes and Effectiveness", Site Principal Investigator, 2010-2014;National Institutes of Health, "OMB Extension for NIH Toolbox for Assessment of Neurological and Behavioral Function", Principal Investigator, 2011;OppNet, the NIH Basic Behavioral and Social Science Opportunity Network Principal Investigator, "Extended Norming for the NIH Toolbox for Assessment of Neurological and Behavioral Function", 2011-2012;A Community Health Applied Research Network (CHARN) funded under the Health Resources and Services Administration (HRSA-10-154), Co-Investigator, 2010-2013
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
American Cancer Society, RSG-01-221-01-PBP, Co-Investigator, 2003-2006
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence to Dr. Weintraub: [email protected]
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

Author Contributions

Sandra Weintraub: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data. Sureyya Dikmen: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, statistical analysis, study supervision. Robert Heaton: drafting/revising the manuscript, study concept or design, analysis or interpretation of data. David Tulsky: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data, statistical analysis, study supervision. Philip Zelazo: drafting/revising the manuscript, study concept or design, analysis or interpretation of data. Patricia Bauer, Noelle Carlozzi, and Jerry Slotkin: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data, study supervision. David Blitz: analysis or interpretation of data, statistical analysis, study supervision. Kathleen Wallner-Allen: drafting/revising the manuscript, study concept or design, analysis or interpretation of data. Nathan Fox: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, study supervision. Jennifer Beaumont: analysis or interpretation of data, statistical analysis. Dan Mungas: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, statistical analysis. Cindy Nowinski: drafting/revising the manuscript, study concept or design, study supervision. Jennifer Richler: drafting/revising the manuscript, study concept or design, acquisition of data. Joanne Deocampo and Jacob Anderson: study concept or design, analysis or interpretation of data, contribution of vital reagents/tools/patients, acquisition of data, statistical analysis, study supervision. Jennifer Manly: drafting/revising the manuscript, acquisition of data. Beth Borosh: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data, study supervision. Richard Havlik: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data. Kevin Conway: drafting/revising the manuscript, study concept or design, study supervision. Emmeline Edwards: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, member of the NIH Project team managing the Tool Box Contract that produced data for this manuscript. Lisa Freund: study concept or design, study supervision, obtaining funding. Jonathan King and Claudia Moy: drafting/revising the manuscript. Ellen Witt: drafting/revising the manuscript, analysis or interpretation of data. Richard Gershon: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data, statistical analysis, study supervision, obtaining funding.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Addressing Participation in Adults With Postconcussive Symptoms Using Cognitive Strategy Training: A Feasibility Trial, The American Journal of Occupational Therapy, 78, 2, (2024).https://doi.org/10.5014/ajot.2024.050396
    Crossref
  2. Psychometrics of drift-diffusion model parameters derived from the Eriksen flanker task: Reliability and validity in two independent samples, Cognitive, Affective, & Behavioral Neuroscience, (2024).https://doi.org/10.3758/s13415-024-01222-8
    Crossref
  3. Functional connectivity and cognitive decline: a review of rs-fMRI, EEG, MEG, and graph theory approaches in aging and dementia, Exploration of Medicine, (797-821), (2024).https://doi.org/10.37349/emed.2024.00256
    Crossref
  4. Biomarkers of Neurodegeneration and Alzheimer’s Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study, Endocrines, 5, 2, (197-213), (2024).https://doi.org/10.3390/endocrines5020014
    Crossref
  5. Real-Time fMRI Neurofeedback Training of Selective Attention in Older Adults, Brain Sciences, 14, 9, (931), (2024).https://doi.org/10.3390/brainsci14090931
    Crossref
  6. Curcumin Supplementation and Vascular and Cognitive Function in Chronic Kidney Disease: A Randomized Controlled Trial, Antioxidants, 13, 8, (983), (2024).https://doi.org/10.3390/antiox13080983
    Crossref
  7. Perturbation-based dual task assessment in older adults with mild cognitive impairment, Frontiers in Rehabilitation Sciences, 5, (2024).https://doi.org/10.3389/fresc.2024.1384582
    Crossref
  8. Children with non-central nervous system tumors treated with platinum-based chemotherapy are at risk for hearing loss and cognitive impairments, Frontiers in Pediatrics, 12, (2024).https://doi.org/10.3389/fped.2024.1341762
    Crossref
  9. Nicotine use during late adolescence and young adulthood is associated with changes in hippocampal volume and memory performance, Frontiers in Neuroscience, 18, (2024).https://doi.org/10.3389/fnins.2024.1436951
    Crossref
  10. Neurologic manifestations of Long COVID in Colombia: a comparative analysis of post-hospitalization vs. non-hospitalized patients, Frontiers in Human Neuroscience, 18, (2024).https://doi.org/10.3389/fnhum.2024.1450110
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share